Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014

Leukemia. 2018 Sep;32(9):2054-2057. doi: 10.1038/s41375-018-0057-5. Epub 2018 Feb 22.
No abstract available

Publication types

  • Historical Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Denmark / epidemiology
  • Female
  • Hematopoietic Stem Cell Transplantation
  • History, 21st Century
  • Humans
  • Immunologic Factors / administration & dosage
  • Male
  • Middle Aged
  • Multiple Myeloma / epidemiology*
  • Multiple Myeloma / history
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy
  • Population Surveillance
  • Prognosis
  • Proteasome Inhibitors / administration & dosage
  • Recurrence
  • Registries
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Proteasome Inhibitors